Temozolomide-Induced RNA Interactome Uncovers Novel LncRNA Regulatory Loops in Glioblastoma

Area of Science:

• Genomics
• Molecular Biology
• Cancer Research

Background:

• Temozolomide (TMZ) resistance is a primary driver of glioblastoma (GBM) recurrence.
• Previous research focused on protein-coding genes, yielding limited therapeutic targets for TMZ resistance.
• The role of long noncoding RNAs (lncRNAs) in drug response remains underexplored.

Purpose of the Study:

• To comprehensively map transcriptome regulation in response to TMZ in patient-derived GBM stem-like cells.
• To identify novel RNA-based regulatory mechanisms contributing to TMZ sensitivity and resistance.
• To discover potential RNA-based predictors for GBM chemosensitivity.

Main Methods:

• RNA sequencing (RNA-seq) and small RNA sequencing (small RNA-seq) were performed on GBM stem-like cells with varying drug sensitivities.
• Integration of public molecular association databases to construct an "RNA interactome".
• Systems-level analysis and computational modeling to identify regulatory circuits involving lncRNAs, transcription factors, mRNAs, and miRNAs.

Main Results:

• A coordinated transcriptional program regulating the response to TMZ was uncovered.
• 22 lncRNAs were identified as being involved in regulatory loops and associated with drug response and glioma prognosis.
• Novel RNA-based predictors of chemosensitivity in GBM were highlighted.

Conclusions:

• lncRNAs play a significant role in the complex regulatory networks governing TMZ response in GBM.
• The identified lncRNAs and regulatory circuits offer potential biomarkers for predicting GBM chemosensitivity.
• The computational approach is adaptable for analyzing drug response in other cancer datasets.